Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women

This study has been completed.
Sponsor:
Collaborator:
MedImmune LLC
Information provided by:
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00689741
First received: May 30, 2008
Last updated: NA
Last verified: May 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2003
  Primary Completion Date: April 2003 (Final data collection date for primary outcome measure)
No publications provided by GlaxoSmithKline

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):